McIlrath & Eck, LLC - VERVE THERAPEUTICS INC ownership

VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 93 filers reported holding VERVE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.42 and the average weighting 0.3%.

Quarter-by-quarter ownership
McIlrath & Eck, LLC ownership history of VERVE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$995
-29.2%
750.0%0.00%
Q2 2023$1,406
+29.9%
750.0%0.00%
Q1 2023$1,082
-25.4%
750.0%0.00%
Q4 2022$1,451
-51.6%
750.0%0.00%
-100.0%
Q3 2022$3,000
+200.0%
750.0%0.00%
Q2 2022$1,000
-50.0%
750.0%0.00%
-100.0%
Q1 2022$2,000
-33.3%
750.0%0.00%0.0%
Q4 2021$3,000
-25.0%
750.0%0.00%0.0%
Q3 2021$4,000750.00%
Other shareholders
VERVE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Alphabet Inc. 10,974,011$515,778,00012.24%
Casdin Capital, LLC 3,038,167$142,794,0003.55%
Redmile Group, LLC 1,869,030$87,844,0001.53%
Logos Global Management LP 443,265$20,833,0001.50%
Novo Holdings A/S 600,000$28,200,0001.46%
Cormorant Asset Management, LP 709,224$32,667,0001.33%
Rock Springs Capital Management LP 962,826$45,253,0000.95%
HighVista Strategies LLC 18,782$883,0000.58%
RA Capital Management 880,284$41,373,0000.57%
Nicholas Investment Partners, LP 132,300$6,218,0000.45%
View complete list of VERVE THERAPEUTICS INC shareholders